论文部分内容阅读
急性心肌梗死(AMI)是指冠状动脉突然完全性闭塞,心肌发生缺血、损伤和坏死,出现以剧烈胸痛,心电图和心肌酶的动态演变为临床特征的急性缺血性心脏病。心肌梗死是一种严重的冠心病,血脂异常、低密度脂蛋白升高已经被认为是导致心肌梗死发生的独立的危险因素。因此,降低低密度脂蛋白、调节血脂成为降低心肌梗死患者并发症的发生率、病死率、病残率[1]的一项治疗手段,
Acute myocardial infarction (AMI) refers to a sudden complete occlusion of the coronary arteries, ischemia, injury and necrosis of the myocardium, and acute ischemic heart disease characterized by a dramatic evolution of chest pain, electrocardiogram, and myocardial enzymes. Myocardial infarction is a serious coronary heart disease, dyslipidemia, elevated low density lipoprotein has been considered an independent risk factor for myocardial infarction. Therefore, lowering LDL and regulating blood lipids has become a therapeutic approach to reduce the incidence of complications, mortality and morbidity in patients with myocardial infarction [1]